Structured evidence table for Quercetin Skin Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Quercetin Skin Randomized Trial | Systemic corticosteroid therapy effectively reduces recurrence rates; however, the severe adverse effects associated with long-term systemic corticosteroid use may outweigh the benefits for RAS patients () (). | 3 | Kong Xiangran (2026) | Advances in the treatment of recurrent aphthous stomatitis: from synthetic and natural drugs to novel drug delivery systems |
| Quercetin Skin Randomized Trial | Notably, the role of local anesthetics (such as lidocaine) in RAS treatment is currently limited to symptomatic pain relief; there is insufficient evidence to suggest that they can alter disease progression, promote ulcer healing, or prevent recurrence (). | 3 | Kong Xiangran (2026) | Advances in the treatment of recurrent aphthous stomatitis: from synthetic and natural drugs to novel drug delivery systems |
| Quercetin Skin Randomized Trial | Topical application of antibiotics, including tetracyclines (e.g., doxycycline, minocycline) and penicillin preparations, can result in lower pain scores, smaller ulcers, and a significant reduction in the healing cycle (). | 3 | Kong Xiangran (2026) | Advances in the treatment of recurrent aphthous stomatitis: from synthetic and natural drugs to novel drug delivery systems |
| Quercetin Skin Randomized Trial | Epidemiological studies indicate a prevalence ranging from 5% to 66% across different countries (). | 3 | Kong Xiangran (2026) | Advances in the treatment of recurrent aphthous stomatitis: from synthetic and natural drugs to novel drug delivery systems |
| Quercetin Skin Randomized Trial | Current therapies mainly alleviate symptoms without addressing underlying immune dysfunction, which has increased interest in nutritional bioactive compounds as preventive or modulatory agents. | 3 | Zafrilla P (2025) | Dietary Bioactive Compounds and Their Role in Allergy Prevention: A Comprehensive Review. |
| Quercetin Skin Randomized Trial | This review summarizes evidence on omega-3 polyunsaturated fatty acids, vitamin D, curcumin, ginger bioactives, quercetin, and epigallocatechin gallate (EGCG) in allergy prevention and management. | 3 | Zafrilla P (2025) | Dietary Bioactive Compounds and Their Role in Allergy Prevention: A Comprehensive Review. |
| Quercetin Skin Randomized Trial | Ginger constituents ([6]-gingerol, [6]-shogaol) modulate Th1/Th2 balance, mast-cell activity, and oxidative stress, with early clinical evidence in rhinitis and asthma. | 3 | Zafrilla P (2025) | Dietary Bioactive Compounds and Their Role in Allergy Prevention: A Comprehensive Review. |
| Quercetin Skin Randomized Trial | Background/Objectives: Allergic diseases are highly prevalent worldwide and represent a significant public health burden. | 3 | Zafrilla P (2025) | Dietary Bioactive Compounds and Their Role in Allergy Prevention: A Comprehensive Review. |
Source documents